NeuroMetrix Announces Sleep Indication for SENSUS™ Pain Management System
July 08, 2013 at 11:42 AM EDT
NeuroMetrix, Inc. (NURO), a medical device company focused on the treatment of the neurological complications of diabetes, reported that the SENSUS Pain Management System became the first transcutaneous electrical nerve stimulator to receive 510(k) clearance (K130919) from the U.S. Food and Drug Administration (FDA) for use during sleep. SENSUS is
